Carmen Chang's Net Worth

$57.6 Million

Estimate Recalculated May 16, 2024 03:34PM EST

Who is Carmen Chang?

Carmen Chang has an estimated net worth of $57.6 Million. This is based on reported shares across multiple companies, which include Bright Health Group Inc., Monte Rosa Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Coursera, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Savara Inc, Trevi Therapeutics, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Regulus Therapeutics Inc., Marker Therapeutics, Inc., and Korro Bio, Inc..

SEC CIK

Carmen Chang's CIK is 0001746342

Past Insider Trading and Trends

2021 was Carmen Chang's most active year for acquiring shares with 16 total transactions. Carmen Chang's most active month to acquire stocks was the month of May. 2021 was Carmen Chang's most active year for disposing of shares, totalling 11 transactions. Carmen Chang's most active month to dispose stocks was the month of May. 2022 saw Carmen Chang paying a total of $350,199,999.40 for 6,926,881 shares, this is the most they've acquired in one year. In 2022 Carmen Chang cashed out on 14,671,143 shares for a total of $750,662.12, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NeueHealth, Inc. (BHG) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 8
Form 4
—
0
—
—
0
Dec 19
Form 4
—
0
—
—
0
Oct 31
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Aug 11
Form 4
—
0
—
—
0
Oct 17
Form 4
—
0
—
—
0
Jan 3
Form 4
∞
71.91M
$18.00
—
71.91M
Jun 28
Form 3
—
0
—
—
0
No matching records found

Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $4.68

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
7.69M
$19.00
—
7.69M
Jun 28
Form 3
—
0
—
—
0
No matching records found

Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $26.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-47.77%
-2.00M
—
—
2.19M
Jun 13
Form 4
∞
4.19M
$15.00
—
4.19M
Jul 22
Form 3
—
0
—
—
0
No matching records found

Coursera, Inc. (COUR) Snapshot price: $17.44

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+51.16%
16.19K
—
—
47.83K
May 24
Form 4
-3.73%
-1.23K
$11.82
-$14,496.59
31.64K
Mar 15
Form 4
+3.87%
1.23K
—
—
32.87K
Feb 15
Form 4
+37.65%
8.65K
—
—
31.64K
May 13
Form 4
∞
22.98K
—
—
22.98K
Nov 1
Form 3
—
0
—
—
0
No matching records found

GENOCEA BIOSCIENCES, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-10.38M
$0.07
-$750,662.12
0
May 24 - May 25
Form 4
+43.61%
3.15M
$2.25
$7,090,335.00
10.38M
Jul 24
Form 4
+65.40%
2.86M
$3.50
$9,999,997.00
7.23M
Jun 24
Form 4
+39.79%
9.95M
$0.47
$4,688,619.18
34.95M
Feb 14
Form 3
—
0
—
—
0
No matching records found